Human Vaccines and Immunotherapeutics
Open Access
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Human Vaccines & Immunotherapeutics is a monthly peer-reviewed medical journal covering research into vaccines and immunotherapeutics in humans. It was established in 2005 as Human Vaccines, and obtained its current name in 2012. It is published by Taylor & Francis and the editor-in-chief is Ronald Ellis (FutuRx). According to the Journal Citation Reports, the journal had a 2013 impact factor of 3.643. Less
Key Metrics
View Chart Journal Specifications
- PublisherTAYLOR & FRANCIS INC
- LanguageEnglish
- FrequencyMonthly
- Article Processing ChargesEUR 2895 | GBP 2495 | USD 3175
- Publication Time11
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- Society/Institute/SponsorInternational Society for Vaccines (ISV)
- FrequencyMonthly
- Publication Start Year2012
- Publisher URL
- Website URL
- Plagiarism
- Publication Time11
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC
- OA statement
| Months | % Papers published |
|---|---|
| 0-3 | 31% |
| 4-6 | 61% |
| 7-9 | 6% |
| >9 | 2% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Human Vaccines and Immunotherapeutics been publishing? 
The Human Vaccines and Immunotherapeutics has been publishing since 2012 till date.
How frequently is the Human Vaccines and Immunotherapeutics published?
Human Vaccines and Immunotherapeutics is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Human Vaccines and Immunotherapeutics?
Human Vaccines and Immunotherapeutics has a H-index score of 80, Citescore of 5.5, SNIP score of 1.36, & SJR of Q1
Who is the publisher of Human Vaccines and Immunotherapeutics?
The publisher of Human Vaccines and Immunotherapeutics is TAYLOR & FRANCIS INC.
Where can I find a journal's aims and scope of Human Vaccines and Immunotherapeutics?
For the Human Vaccines and Immunotherapeutics's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Human Vaccines and Immunotherapeutics on editage?
For the Human Vaccines and Immunotherapeutics metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Human Vaccines and Immunotherapeutics?
The eISSN number is 2164-554X and pISSN number is 2164-5515 for Human Vaccines and Immunotherapeutics.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Clinical trial, Human papillomavirus, Immunization, Influenza vaccine, Polysaccharide, Streptococcus pneumoniae, Immunotherapy, Social media, Performance improvement, Measles, Randomized controlled trial, Burden of disease, Rotavirus, Public health, Confidence interval, Hepatitis B, Seroconversion, Virus, Antigen, Conjugate vaccine.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.